Sitagliptin And Metformin Hydrochloride Tablet, Film Coated
Product Images NDC 84677-053

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitagliptin And Metformin Hydrochloride (NDC 84677-053). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

84677-052-60-sitagliptin Mtfm HCl 50.500mg 60ct-rev.0826.jpg (84677 052 60 Sitagliptin Mtfm HCl 50.500mg 60ct Rev.0826)

Label for Sitagliptin and Metformin Hydrochloride Tablets, dosage strength 50 mg/500 mg. The oral film-coated tablet package contains 60 tablets and is marketed by Golden State Medical Supply, Inc. The label includes usage instructions, storage conditions, a barcode, and a QR code for additional information.*

FDA Label Image

84677-053-60-sitagliptin Mtfm HCl 50.1000mg 60ct-rev.0826.jpg (84677 053 60 Sitagliptin Mtfm HCl 50.1000mg 60ct Rev.0826)

Label for Sitagliptin and Metformin Hydrochloride tablets, film coated, 50 mg/1000 mg strength, oral dosage form. The label indicates a 60-tablet quantity, with the product marketed by Golden State Medical Supply, Inc. Dosage and storage instructions are included, along with NDC code 84677-053-60 and a QR code for additional information.*

FDA Label Image

Sitagliptinmetformin-01 (Sitagliptinmetformin 01)

Chemical structure of Sitagliptin and Metformin Hydrochloride as shown in the molecular diagram, including associated phosphate and water molecules.*

FDA Label Image

Sitagliptinmetformin-02 (Sitagliptinmetformin 02)

Chemical structure diagram of Sitagliptin and Metformin Hydrochloride, showing molecular components including methyl groups, amide and amine groups, alongside hydrochloride (HCl).*

FDA Label Image

Sitagliptinmetformin-03 (Sitagliptinmetformin 03)

A line graph showing the least squares mean change from baseline over 24 weeks for various treatments including placebo, Sitagliptin 100 mg once daily, Metformin 500 mg twice daily, Metformin 1000 mg twice daily, and combinations of Sitagliptin 50 mg with Metformin 500 mg or 1000 mg twice daily. The vertical axis represents change from baseline, and the horizontal axis represents time in weeks. The graph compares the efficacy of these treatments.*

FDA Label Image

Sitagliptinmetformin-04 (Sitagliptinmetformin 04)

A line graph depicting the Least Squares Mean Change from Baseline over 52 weeks, comparing Sitagliptin 100 mg and Glipizide. The x-axis represents time in weeks, and the y-axis shows mean change values, with both treatments showing similar trends in the data points over the study period.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.